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INTRODUCTION
 
Borna disease virus (BDV) is an enveloped, negative-strand-
ed, and highly neurotropic RNA virus. It mainly infects the lim-
bic system, hippocampus, and cerebellum. Animals infected 
with BDV show various symptoms such as aggression, ataxia, 
hyperexcitability, and stereotypic behaviour reminiscent of psy-
chiatric symptoms in human. Due to those similarities, BDV has 
been considered to be a possible zoonotic agent that may con-
tribute to psychiatric disease.
1
Although various warm-blooded animals could be infected 
with BDV, horses have been known to be the main natural hosts.
2 
BDV infection causes delayed immunopathology and most an-
imals infected with BDV are asymptomatic.
3 Inoue et al. has re-
vealed that 18 out of 35 (51.4%) horses infected with BDV could 
be seropositive for BDV without any clinical symptoms for 4 
consecutive years.
4 
Initially, BDV infection has been known to be endemic main-
ly in central Europe such as Germany and Austria.
5 However, 
now it has been reported that horses infected with BDV could 
be found in Asia.
6-11 The prevalence of BDV antibodies or RNA 
in asymptomatic horses in Asia is as follows: 16.7-29.8% in Ja-
pan,
4,12,13 20% in China,
7 and 23.5-41.2% in Iran.
6 There have 
been also evidences that people living near animals could be 
infected with BDV.
12,14
Despite the growing evidences of the BDV infection in Asia, 
there has been no report on the BDV prevalence in animals 
in Korea. Previously, we examined BDV RNA in race horses and 
jockeys riding the horses using by one-tube reverse transcrip-
tase Polymerase Chain Reaction (PCR) (RT-PCR) and nested 
RT-PCR, but failed to detect BDV RNA in horses and jock-
eys.
15 Thus in this study, we aimed to investigate BDV markers 
by other methods, real time RT-PCR (rRT-PCR). Considering 
some evidences indicating discrepancies between serologic 
study and RT-PCR result,
16,17 we used both indirect immuno-
fluorescence antibody (IFA) test and rRT-PCR to compare the 
results of two methods. We also tried to examine the correlation 
between the prevalence of BDV in the horses and jockeys. 
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METHODS
Subjects 
Thirty-nine race horses (nine were thoroughbred, 30 were 
cross-bred) were included in the study. Twenty-three horses 
were female, and 16 male. The mean age of the horses was 3.1 
years (SD=3.3, range: 1-15 years). Clinical and neurological ex-
aminations of the horses were performed by a veterinarian. All 
horses were in a healthy condition. The study protocol was ap-
proved by the Ethics Committee of Korea University.
Forty-eight jockeys were also included. Their mean age was 
31.2 years (SD=5.5, range: 22-40 years), and their mean dura-
tion of contact with horses was 11.2 years (SD=5.8, range: 1-22 
years). None had any psychiatric or medical illness, as assessed 
by means of clinical interviews and physical examinations. Three 
jockeys had a current familial history of psychiatric illness (2 de-
pression, 1 alcoholism). All the subjects in this study were in-
cluded in our previous study.
15 Informed consent was obtained 
from the jockeys and the Seoul Horse Race Association.
Preparation of peripheral blood mononuclear cells 
A sample of fasting blood (20 mL) was drawn from each sub-
ject. Preparation of peripheral blood mononuclear cells (PBMCs) 
were isolated from anticoagulant(lithium heparin)-treated 
blood by Ficoll-hypaque gradient centrifugation. Total RNA 
was extracted from PBMCs using RNAzol (Gibco/BRL, Gaith-
ersburg, MD).
 
Serological detection of BDV infection with indirect 
immunofluorescent antibody test
Indirect immunofluorescent antibody (IFA) test was conduct-
ed according to the method previously described.
18 The Ma-
dine Darby canine kidney (MDCK) cell line and MDCK cell 
line persistently infected with BDV (MDCK-BDV)
19 cultured 
for 5 days with Dulbecco’s Modified Eagle Medium (DMEM) 
(Gibco/BRL, Germany) supplemented with 10% fetal bovine 
serum (FBS) (Gibco/BRL, Germany), were trypsinized, suspend-
ed in phosphate buffered saline (PBS), spotted onto Teflon-coat-
ed 10-well slides, and air-dried in room temperature. Cells on 
the 10-well antigen slide were fixed with anhydrous acetone at 
-20°C for 7 minutes and dried. Human and horse serum sam-
ples diluted in PBS as 1 : 32 were treated to MDCK cell and 
MDCK-BDV cell on antigen slide and the slide was incubat-
ed in humidity chamber at 37°C for 30 minutes. After three 
washes with PBS, Fluorescein isothiocyanate conjugated anti-
human immunoglobulin goat IgG (MP Biomedicals Inc., USA) 
was added to each well and the slide was incubated in humidi-
ty chamber at 37°C for 30 minutes. The slides were mounted 
with glycine-buffered glycerol under cover slips and examined 
for characteristic cytoplasmic fluorescent pattern with a fluo-
rescence microscope.
 
Genetic detection of viral genomic RNA with 
real-time reverse transcription-polymerase 
chain reaction 
Real-time quantitative RT-PCR for nucleoprotein (p40) and 
phosphoprotein (p24) genes of BDV was performed to detect 
RNA genome of BDV in PBMCs. The primers and probes de-
scribed in previously study were used for rRT-PCR.
20 For the 
construction of the quantitative standard, p40 and p24 genes 
were amplified by RT-PCR and cloned to pGEM-T Easy vector 
system (Promega, USA). Cloned p40 and p24 genes were tran-
scribed to RNA using the MEGAscript T7 transcription kit (Am-
bion Inc., USA) in accordance with the manufacturer’s instruc-
tions. The amounts of p40 and p24 RNA transcribed using by 
in vitro transcription system were measured by optical density. 
p40 and p24 RNA were used for the reverse transcription reac-
tion template from 1×1,010 copies/μL to 1×103 copies/μL dilut-
ed by 10-fold dilution method. After the reverse transcription 
reaction, the Taqman Universal PCR Master Mix (applied Bio-
systems, USA) was used for the real-time PCR reaction as rec-
ommended by manufacturer’s instruction. The real-time PCR 
reaction mixtures were incubated for 10 minutes at 95°C; 40 
cycles of amplification were performed using ABI PRISM 7000 
Sequence Detection System (Applied Biosystems, USA). Each 
cycle consisted of a denaturation step (15 seconds at 95°C) and 
an annealing-elongation step (1 minute at 60°C). Threshold cy-
cle (Ct) values, i.e., the number of cycles for fluorescence to reach 
to clearly detectable levels, over 40 were regarded as negative.
Statistical analysis
To analyze demographic data, two-tailed t-test was used for 
continuous covariates. For discrete covariates, chi-square test 
was used. The null hypothesis was rejected at p<0.05. The sta-
tistical package used for the analysis was Statistical Package for 
the Social Sciences 11.01.
RESULTS
The p24 and p40 RNA were not detected by rRT-PCR in the 
horses and jockeys. Indirect IFA was conducted for the sero-
logical detection of BDV antibodies. No BDV antibody was de-
tected by IFA in the horses and jockeys.
 
DISCUSSION
 
We failed to demonstrate BDV RNA and antibody from 
PBMCs in race horses and jockeys. This result is contrary to 
several previous studies demonstrating BDV infection in healthy 
horses in Asia. In Japan, Nakamura et al.
13 found that 17 out 60  Psychiatry Investig 2011;8:58-60
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of 57 (29.8%) healthy horses were RNA positive and Takahashi 
et al.
12 reported that 7 out of 54 (12.9%) healthy thoroughbred 
race horses and 4 out of 57 (7.0%) blood donors living near 
those horses were RNA positive, while in Iran, Bahmani et al.
6 
reported an RNA positive rate of 23.6% in healthy race horses 
(17 out of 72). 
Two main reasons might account for the difference between 
this study and previous Asian reports of BDV occurrence. The 
first possibility is the difference in diagnostic tools. All of the 
above mentioned studies detected BDV RNA by nested RT-
PCR, which is highly sensitive to contamination, indeed Du-
rrwald et al.
21 suggested that most of the BDV positive report-
ed using nested RT-PCR might actually be the result of inad-
vertent sample contamination. In this study we used rRT-PCR 
to detect BDV RNA, which has no carry-over contamination 
risk.
22 The second possibility is that, in contrast to other areas 
in Asia, Korea may not be a BDV-endemic area. This agrees 
with our previous studies which have failed to detect BDV anti-
bodies and RNA in psychiatric patients in Korea
23 and Japan.
24 
We also used lithium heparin-treated blood for preparation of 
total RNA from PBMCs. However, ethylenediaminetetraacetic 
acid is better than heparin as anticoagulant because heparin inhib-
its the reaction of RT-PCR. 
Limitations to this study include its small sample size and re-
stricted region. To accurately determine the BDV prevalence in 
Korea, large-scaled study should be performed in several differ-
ent regions.
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